Company intelligence / Profile preview

Biokit

Lliçà d’Amunt, Barcelona province, Spainbiokit-eg.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biokit is a leading developer and manufacturer of in vitro diagnostic reagents and systems, specializing in immunoassays based on antigen–antibody reactions. The company invests heavily in R&D (~15% of turnover), has a global presence through OEM partnerships, and recently entered into licensing agreements to incorporate novel Affimer-based reagents into its product portfolio. No clinical trial results as it is not a therapeutics company.

Therapeutic areas: HematologyInfectious Diseases
Modalities: Diagnostic reagentsImmunoassaysIn vitro diagnostic devices
Industry: Protein Biomarker Diagnostics

Partnerships

Avacta Group plc

Beyond the preview

Go deeper on Biokit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biokit.

Explore the full profile